More Stories From Conquest
How MD Anderson is preparing for health reform
With the passage of the Affordable Care Act in 2010 and most provisions due to take effect in 2014, it’s reasonable to ask what MD Anderson is doing to prepare.
A drug. A disease. Three studies. Four investigators.
Bevacizumab fails newly diagnosed glioblastoma patients
Diagnostic tool may help predict right patients for bevacizumab
Bevacizumab reduces cognitive function and quality of life
Creating an umbrella of care
Patients in cancer treatment often have other health issues that can affect treatment and/or quality of life. Over the past 25 years, MD Anderson has added myriad services to handle these conditions while providing quality care for patients.
Seed, soil and metastasis
In 1889, Stephen Paget, an English surgeon and pathologist, hypothesized that metastasis (the spread of cancer) did not occur randomly. It took nearly a century before Isaiah Fidler came along to prove him right.
50 years of educating scientists
As the graduate school celebrates its 50th anniversary, its two leaders assess their first year as deans and look forward to an exciting future.
Understanding epigenetics to develop new therapies
Some might call it fate. Three scientists who started their careers in different parts of the world and come from different scientific disciplines now work together at MD Anderson to develop new treatments for patients.